Abstract
Background
Heterogeneous survival rates in patients with similar clinicopathologic characteristics or molecular prognostic markers have been noted. This study was conducted to evaluate the prognostic effect of lymphatic and/or blood vessel invasion (LBVI), identified by routine hematoxylin and eosin staining, on the outcome of patients with node-negative advanced gastric cancer.
Methods
A total of 280 patients who underwent curative gastrectomy for advanced gastric cancer without lymph node metastasis were retrospectively reviewed. Univariate and multivariate analyses of the clinicopathological features, recurrences, and prognoses of patients with and without LBVI were performed.
Results
Lymphatic vessel invasion (LVI) was noted in 20.0%, blood vessel invasion (BVI) in 5.4%, and either LVI or BVI in 22.5%. None of the clinicopathologic features was related to LBVI. Patients with LBVI had a recurrence rate of 26.8%, whereas patients without LBVI had a recurrence rate of 13.5% (P=.018). The 5-year survival rates were 82.4% for patients without LBVI and 67.1% for patients with LBVI (P=.0222). LBVI was shown to be an independent risk factor for recurrence (relative risk, 2.30; 95% confidence interval, 1.06–4.99) and poor prognosis (relative risk, 1.88; 95% confidence interval, 1.07–3.29).
Conclusions
LBVI is an adverse prognostic indicator and the presence of LBVI seems to provide useful information for the prognosis and clinical management of patients with node-negative advanced gastric carcinoma.
Similar content being viewed by others
References
Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma.Br J Surg 2000;87:236–42.
Park CH, Byun JY, Kim BK, Kim IC. Recurrent gastric cancer after curative surgery.J Korean Cancer Assoc 1998;30:488–96.
Becker KF, Keller G, Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer.Surg Oncol 2000;9:5–11.
Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.Ann Surg 1998;228:449–61.
Kim JP. Surgical results in gastric cancer.Semin Surg Oncol 1999;17:132–8.
Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.Cancer 1993;72:2089–97.
Maruyama K. The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analysis.Scand J Gastroenterol Suppl 1987;22:63–8.
Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion.J Clin Oncol 1988;6:119–27.
Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.Cancer 1966;78:2111–8.
Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.Cancer 1995;76:1772–8.
Brucher BL, Stein HJ, Werner M, Siewert JR. Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma.Cancer 2001:92:2228–33.
Gabbert HE, Meier S, Gerharz CD, Hommel G. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients.Int J Cancer 1991;49:203–7.
Setala LP, Kosma VM, Marin S, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.Br J Cancer 1996;74:766–72.
Maehara Y, Oshiro T, Baba H, Ohno S, Kohnoe S, Sugimachi K. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer.Surgery 1995;117: 380–5.
Sobin LH, Wittekind C.International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, 1997:59–62.
Nishi M, Omori Y, Miwa K.Japanese Research Society for Gastric Cancer (JRSGC). Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1995:6–15.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.
Cox DR. Regression models and life tables.J R Stat Soc 1972;34: 187–220.
Noguchi Y. Blood vessel invasion in gastric carcinoma.Surgery 1990;107:140–8.
Inada K, Shimokawa K, Ikeda T, Ozeki Y. The clinical significance of venous invasion in cancer of the stomach.Jpn J Surg 1990;20:545–52.
Sugarbaker EV. Patterns of metastasis in human malignancies.Cancer Biol Rev 1981;2:235–78.
Adachi Y, Mori M, Maehara Y, Kitano S, Sugimachi K. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses.J Am Coll Surg 1997;184:373–7.
Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients.J Surg Oncol 2000; 73:153–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hyung, W.J., Lee, J.H., Choi, S.H. et al. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Annals of Surgical Oncology 9, 562–567 (2002). https://doi.org/10.1007/BF02573892
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02573892